TNFRSF10B and Miyoshi myopathy: Next, we evaluated the ability of our CAR-NK92-TRAIL cells to mediate cytotoxic activity against our panel of cancer cell lines, consisting of four DR5+/BCMA+ MM cell lines: RPMI 8226, MM1.S, U266, and KMS-12-PE.